Guru Ownership Over Time
Guru Analysis for CRISPR Therapeutics AG (CRSP)
CRISPR Therapeutics AG (CRSP), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q3 2025, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $552.71 M.
Top institutional holders include Catherine Wood and Cliff Asness.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $25.42 M net outflow during the quarter.
Recent activity highlights Cliff Asness who increased their stake by 31.3%. Conversely, Catherine Wood reduced exposure by 3.9%.
| Portfolio Manager | % of portfolio | Activity | Shares | Value | Peroid |
|---|---|---|---|---|---|
| 3.78% | Reduce -3.9% | 9,786,973 | $634.29 M | Q3 2025 | |
| 0.00% | Add 31.3% | 28,372 | $1.84 M | Q3 2025 | |
| 0.01% | Add 4.3% | 10,682 | $692,300 | Q3 2025 |
| Period | Portfolio Manager | Activity | Share change | % change to portfolio |
|---|
| Period | Portfolio Manager | Activity | Share change | % change to portfolio |
|---|
| Period | Portfolio Manager | Activity | Share change | % change to portfolio |
|---|
| Portfolio Manager | Option Type | % of portfolio | Activity | Shares | Value | Period |
|---|
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown(Q3 2025)
Guru Consensus (Q3 2025)
FAQs for CRISPR Therapeutics AG (CRSP)
Top Guru holders include Catherine Wood ($634.29 M), Cliff Asness ($1.84 M), Murray Stahl ($692,300). Collectively, tracked Gurus hold 9.83 M shares.
Based on recent 13F filings, the sentiment is **Negative (Net Sell)**. There was a net outflow of $25.42 M, with 2 Gurus buying and 2 Gurus selling.
In the recent quarter, 1 Gurus reduced their positions, and 1 Gurus sold out of CRSP completely. Total sell value was $25.89 M.
Yes, 0 Gurus opened new positions in CRSP, and 2 added to their existing holdings. Total buy value was $466,697.19.